WHAT'S
NEW
New Resources
Updated Fundraising and Advocacy Toolkit - In English and French
The toolkits now include updated versions of the endemic countries list, case
statement, and PowerPoint presentation. Click
here to link to
the updated French version of the toolkit. Click
here to link to the updated English version of the toolkit from the Global Alliance to Eliminate LF. Download documents and pictures including background
information about LF and the global program; advocacy strategies; and
fundraising guidelines, including a sample grant proposal. Join our
toolkit group email list to receive regular updates by
emailing us.
New Advocacy Activities
On June 10th, 2005, the Global Health Council arranged a Congressional briefing
on neglected diseases (with a focus on LF, onchocerciasis, trachoma,
schistosomiasis, leprosy, and intestinal helminths). The meeting was
moderated by the LF Support Center's Dr. Eric Ottesen, and presentations were
made by Dr. Peter Hotez (The George Washington University), Dr. David Molyneux
(Director of the LF Support Centre at the Liverpool School of Tropical
Medicine), and Ms. Paula Luff (Pfizer). For Dr. Hotez's presentation
introducing the neglected diseases, click here.
For Dr. Molyneux's presentation on integrated control, click
here. For Ms. Luff's
presentation on public-private partnerships, click
here.
New Fundraising Activities
Sandra Libunao,
our external fundraising training consultant, visited Kenya, Burkina Faso, Mali,
and Niger in the first half of 2005. Elimination programs in these
countries are in various stages of conception and implementation. In
Niger, the Ministry of Health is yet to install the LF program. Sandra's
visit to Niger and her meeting with the Minister will hopefully hasten the
process. Mali's LF program has been recently installed, but its Mass Drug
Administration (MDA) is yet to begin due to a lack of resources. With
Sandra's visit and her meetings with principals within the Ministry of Health,
including the Minister, some funds will more likely be allocated to allow the
MDA to take place before the end of the year. Kenya's LF program has
begun, but is in need of resources to complete the mapping process and to
continue to upscale MDA. Burkina Faso's MDA may yet receive substantial
support from within the Ministry after Sandra's third visit where advocacy
within the Ministry has been a top priority.
En route to Kenya in February 2005, she stopped over in Johannesburg to meet
primarily with NGO funding agencies to introduce the LF program and seek
support.
As clearly indicated,
one important purpose of the visits to Mali and Niger was principally to meet
with the Ministry of Health in each country in order to ensure the commitment of
the Ministry of Health to implementing LF elimination programs within the
Ministry. In all countries, Sandra worked with the national LF program
managers and their fundraising coordinators (as in the case of Burkina Faso) to
identify and meet prospective donors in an effort to help endemic countries
raise program funds.
For additional information on our
innovative in-country fundraising, please contact the LF Support Center, at
gaelf@emory.edu.
New Journal Articles
"Defining the cost of the Egyptian
lymphatic filariasis elimination programme"
estimates the costs of two rounds
of mass drug administration conducted in Egypt in 2000 and 2001, the average
cost per person treated, and the cost share of the different program partners.
To read the article, click
here.
"Treatment strategies underpinning the
global programme to eliminate lymphatic filariasis" reviews the evidence that
demonstrates the safety and efficacy of the dual drug treatment program (albendazole
+ ivermectin or albendazole + DEC). Recommendations are made for further
developments in using chemotherapy for LF. To read the article, click
here.
LF Support Center Home Page |
Background |
Research |
About Lymphatic Filariasis
LFSC Publications |
Resources |
LF Links |
LFSC Staff |
Contact Us |
What's New
|